Daiwa Securities Group Inc. Deciphera Pharmaceuticals, Inc. Transaction History

Daiwa Securities Group Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$14.85 - $19.04 $1,084 - $1,389	73 Added 36.68%	272 $4,000
Q3 2021 Nov 05, 2021	BUY	$26.46 - $37.15 $2,434 - $3,417	92 Added 85.98%	199 $7,000
Q4 2020 Feb 04, 2021	SELL	$51.77 - $66.18 $10,923 - $13,963	-211 Reduced 66.35%	107 $6,000
Q3 2020 Nov 02, 2020	BUY	$43.8 - $58.16 $700 - $930	16 Added 5.3%	318 $16,000
Q1 2020 May 14, 2020	BUY	$33.63 - $69.4 $470 - $971	14 Added 4.86%	302 $12,000
Q4 2019 Jan 31, 2020	SELL	$31.7 - $69.93 $760 - $1,678	-24 Reduced 7.69%	288 $18,000
Q3 2019 Nov 04, 2019	BUY	$19.95 - $38.85 $1,436 - $2,797	72 Added 30.0%	312 $11,000
Q1 2019 Apr 26, 2019	SELL	$20.65 - $29.55 $1,858 - $2,659	-90 Reduced 27.27%	240 $6,000
Q4 2018 Feb 05, 2019	BUY	$19.08 - $36.14 $6,296 - $11,926	330 New	330 $7,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.